Work Here?
Industries
Biotechnology
Healthcare
Company Size
11-50
Company Stage
IPO
Headquarters
Baltimore, Maryland
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$9.9M
Above
Industry Average
Funded Over
3 Rounds
BullFrog AI appoints Josh Blacher as Chief Financial Officer.
Bullfrog AI announces closing of registered direct offering and concurrent private placement for aggregate gross proceeds of $3.13 million.
BullFrog AI raises $3.13M in stock offering: Learn how this AI company's strategic move impacts investors and the tech landscape. Discover key details and potential market effects.
GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) - BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of John Baldoni, Ph.D., to its Scientific Advisory Board.
BullFrog AI appoints globally renowned biomedical AI expert Dr. Thomas W. Chittenden as Chief Scientific Officer.
Find jobs on Simplify and start your career today
Industries
Biotechnology
Healthcare
Company Size
11-50
Company Stage
IPO
Headquarters
Baltimore, Maryland
Founded
2017
Find jobs on Simplify and start your career today